Press Releases July 2, 2026 04:05 PM

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026

Merit Medical Systems schedules Q2 2026 earnings release and investor conference call for July 30, 2026

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
MMSI

Merit Medical Systems, a global healthcare technology company, announced that it will release its financial results for Q2 2026 after market close on July 30, 2026, and will host a conference call that same day to discuss the results. The company specializes in developing and distributing proprietary medical devices for interventional, diagnostic, and therapeutic procedures across multiple medical specialties.

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
MMSI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Earnings release scheduled for after market close on July 30, 2026.
  • Conference call and webcast planned the same day to discuss financial results.
  • Merit Medical Systems develops and distributes medical devices across cardiology, radiology, oncology, critical care, and endoscopy.

SOUTH JORDAN, Utah, July 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2026, after the close of the stock market on Thursday, July 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, July 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific).

To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.

A live webcast and slide deck can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at www.merit.com.

ABOUT MERIT
Founded in 1987, Merit is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,500 people worldwide.

Contacts:

 PR/Media Inquiries:
Sarah Comstock
Merit MedicalInvestor Inquiries:
Mike Piccinino, CFA, IRC
ICR Healthcare+1-801-432-2864+1-443-213-0509sarah.comstock@merit.commike.piccinino@icrhealthcare.com

Risks

  • Financial results may not meet market expectations, impacting stock performance.
  • General market volatility around earnings season can lead to price fluctuations.
  • Healthcare regulatory changes and market demand dynamics could affect future performance.

More from Press Releases

Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner Sep 30, 2026 Powerus to Complete Merger with Aureus Greenway Holdings October 1 and Trade as PUSA on Nasdaq Sep 30, 2026 Top Ships Inc. Announces Closing of the Acquisition of three High Specification Newbuilding MR Tankers Sep 30, 2026 Actelis Networks to Present at The ThinkEquity Conference 2026 Sep 30, 2026 Viper Energy, Inc., a Subsidiary of Diamondback Energy, Inc., Schedules Third Quarter 2026 Conference Call for November 3, 2026 Sep 30, 2026